Suivre
C. Michael Gibson, M.D.
C. Michael Gibson, M.D.
Harvard Medical School
Adresse e-mail validée de bidmc.harvard.edu - Page d'accueil
Titre
Citée par
Citée par
Année
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...
Circulation 125 (1), e2-e220, 2012
30976*2012
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
28961*2016
Prasugrel versus clopidogrel in patients with acute coronary syndromes
SD Wiviott, E Braunwald, CH McCabe, G Montalescot, W Ruzyllo, ...
New England Journal of Medicine 357 (20), 2001-2015, 2007
81172007
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta, J Eikelboom, S Kaul, ...
Circulation 123 (23), 2736-2747, 2011
41652011
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ...
Journal of the American college of cardiology 75 (23), 2950-2973, 2020
33192020
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
New England Journal of Medicine 352 (12), 1179-1189, 2005
29042005
TIMI frame count: a quantitative method of assessing coronary artery flow
CM Gibson, CP Cannon, WL Daley, JT Dodge Jr, B Alexander, SJ Marble, ...
Circulation 93 (5), 879-888, 1996
26331996
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
CP Cannon, WS Weintraub, LA Demopoulos, R Vicari, MJ Frey, N Lakkis, ...
New England Journal of Medicine 344 (25), 1879-1887, 2001
25582001
Rivaroxaban in patients with a recent acute coronary syndrome
JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ...
New England Journal of Medicine 366 (1), 9-19, 2012
24262012
Prevention of bleeding in patients with atrial fibrillation undergoing PCI
CM Gibson, R Mehran, C Bode, J Halperin, FW Verheugt, P Wildgoose, ...
New England Journal of Medicine 375 (25), 2423-2434, 2016
16282016
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
CP Cannon, CM Gibson, CT Lambrew, DA Shoultz, D Levy, WJ French, ...
Jama 283 (22), 2941-2947, 2000
16092000
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised …
G Montalescot, SD Wiviott, E Braunwald, SA Murphy, CM Gibson, ...
The Lancet 373 (9665), 723-731, 2009
13832009
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
TD Henry, BH Annex, GR McKendall, MA Azrin, JJ Lopez, FJ Giordano, ...
Circulation 107 (10), 1359-1365, 2003
13612003
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
CM Gibson, CP Cannon, SA Murphy, KA Ryan, R Mesley, SJ Marble, ...
Circulation 101 (2), 125-130, 2000
12232000
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
MS Sabatine, DA Morrow, JA de Lemos, CM Gibson, SA Murphy, N Rifai, ...
Circulation 105 (15), 1760-1763, 2002
10412002
Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial
EM Antman, RP Giugliano, CM Gibson, CH McCabe, P Coussement, ...
Circulation 99 (21), 2720-2732, 1999
9951999
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
Jama 294 (10), 1224-1232, 2005
9602005
Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
SJ Connolly, TJ Milling Jr, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ...
New England Journal of Medicine 375 (12), 1131-1141, 2016
9222016
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy
RH Chan, BJ Maron, I Olivotto, MJ Pencina, GE Assenza, T Haas, ...
Circulation 130 (6), 484-495, 2014
9142014
Effect of platelet inhibition with cangrelor during PCI on ischemic events
DL Bhatt, GW Stone, KW Mahaffey, CM Gibson, PG Steg, CW Hamm, ...
New England Journal of Medicine 368 (14), 1303-1313, 2013
8872013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20